ARKOFARM

ARKO CAPSULES HORSE CHESTNUT 45 CAPSULES

ARKO CAPSULES HORSE CHESTNUT 45 CAPSULES

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet
Arkopharma

FLUIDITY

HORSE CHESTNUT

Aesculus hippocastanum

ARKOCAPS

Cryocrushed horse chestnut bark powder ( Aesculus hippocastanum L. ).
Capsule of vegetable origin: hydroxypropylmethylcellulose obtained from bark titrated to at least 1.5% in Esculoside.
Horse chestnut is rich in active ingredients that promote microcirculation function. Horse chestnut can contribute to leg health.

How to use
1 or 2 capsules, 2 times a day with a large glass of water, preferably before meals.

Format
45 capsules.

Cod. 91010177

ARKOFARM

ARKO CAPSULES HORSE CHESTNUT 45 CAPSULES

ARKO CAPSULES HORSE CHESTNUT 45 CAPSULES

MINSAN code: 909366890
EAN Code: 3578831410420
Previous price: €14,30
Regular price €14,30
Regular price €16,90 Sale price €14,30
-15% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.